A Phase 3, Randomized, Double-blind, Active-controlled, Multicenter Study to Evaluate the Efficacy and Safety of a Triple Therapy With Tegoprazan, Amoxicillin, and Clarithromycin in H. Pylori Positive Patients

Trial Profile

A Phase 3, Randomized, Double-blind, Active-controlled, Multicenter Study to Evaluate the Efficacy and Safety of a Triple Therapy With Tegoprazan, Amoxicillin, and Clarithromycin in H. Pylori Positive Patients

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 18 May 2018

At a glance

  • Drugs Amoxicillin (Primary) ; Clarithromycin (Primary) ; Tegoprazan (Primary) ; Lansoprazole
  • Indications Helicobacter pylori infections; Peptic ulcer
  • Focus Registrational; Therapeutic Use
  • Sponsors CJ Corporation
  • Most Recent Events

    • 04 May 2018 Planned initiation date changed from 30 Apr 2018 to 25 May 2018.
    • 17 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top